HART-II: Heart Failure Adherence and Retention Trial II

      -Late-Breaking Clinical Trial Results Presented at ACC 2000 by Dr. A. Ross

HAT: The Home Automated External Defibrillator Trial

      -Late-Breaking Clinical Trial Results Presented at ACC 2008 by Dr. Gust H. Bardy

HDL Cholesterol Study

      -Effects of High Doses of Simvastatin and Atorvastatin on High-Density Lipoprotein Cholesterol and Apolipoprotein A-1 by Dr. John R. Crouse III

HFHC: The Heart Failure Home Care Trial

      -Late-Breaking Clinical Trial Results Presented at ACC 2008 by Dr. Ozlem Soran

HOPE: Heart Outcomes Prevention Evaluation

      -Effects of an Angiotensin-Converting Enzyme Inhibitor, Ramipril, on Death from Cardiovascular Causes, Myocardial Infarction, and Stroke in High-Risk Patients by the HOPE Study Investigators

HORIZONS AMI: Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction

      -Protocol Procedures and Overview by Dr. Gregg W. Stone

      -Paclitaxel-Eluting TAXUS Stents vs. Bare Metal Stents During Primary Angioplasty in Acute Myocardial Infarction (AMI): One Year Results Presented at TCT 2008 by Dr. Gregg W. Stone

      -Bivalirudin vs. Heparin Plus Glucoprotein IIb/IIIa Inhibitors During Primary Angioplasty in Acute Myocardial Infarction: 30 Day Results by Dr. Gregg W. Stone

      -Study Design Presented at TCT 2005

      -Infarct Size after Primary Angioplasty Patients With Bivalirudin Compared to Unfractionated Heparin Plus Abciximab in STEMI: MRI Substudy Presented at TCT 2009 by Dr. Jochen Wöhrle

      -Presention at a Non-PCI Facility Requiring Transfer on Long-Term Prognosis in STEMI Patients Undergoing Primary Angioplasty: 1-Year Results Presented at TCT 2009 by Dr. Jochen Wöhrle

      -Impact of Clopidogrel Loading Dose on the Safety and Effectiveness of Bivalirudin in Patients Undergoing Primary Angioplasty for AMI: Presented at ACC 2008 by Dr. George Dangas

      -Predictors of Acute, Subacute and Late Stent Thrombosis After Acute MI Primary Angioplasty: Presented at ACC 2009 by Dr. George Dangas

      -Stent Thrombosis Following Primary PCI in STEMI: Predictors, Clinical Impact and Preventive Strategies: Presented at TCT 2009 by Dr. George Dangas

      -Impact of Baseline Renal Function on the Safety and Effectiveness of Bivalirudin in Patients with Acute MI Undergoing Primary Angioplasty: Presented at ACC 2008 by Dr. Roxana Mehran

      -Bivalirudin vs. Heparin Plus Glycoprotein IIb/IIIa Inhibitors During Primary Angioplasty in Acute Myocardial Infarction: One Year Results Presented at TCT 2008 by Dr. Roxana Mehran

      -Impact of Advanced Age on the Safety and Effectiveness of Bivalirudin in Patients with Acute Myocardial Infarction Undergoing Primary Angioplasty: Presented at ACC 2008 by Dr. Dariusz Dudek

      -Impact of Diabetes Mellitus on the Safety and Effectiveness of Bivalirudin in Patients with AMI Undergoing Primary Angioplasty: Presented at ACC 2008 by Dr. Bernhard Witzenbichler

      -Impact of Gender on the Safety and Effectiveness of Bivalirudin in Patients with Acute Myocardial Infarction Undergoing Primary Angioplasty: Presented at ACC 2008 by Dr. L. Grinfeld

      -Major Adverse Events in STEMI Patients Treated with Primary Angioplasty Occur More Frequently at U.S. Compared with Non U.S. Sites: Presented at ACC 2008 by Dr. Bruce R. Brodie

      -A Prospective, Randomized Comparison of Paclitaxel-eluting TAXUS Stents vs. Bare Metal Stents During Primary Angioplasty in Acute Myocardial Infarction - One Year Results by Dr. Gregg W. Stone (TCT 2008)

      -Two-Year Follow-Up From a Prospective, Randomized Trial of Heparin Plus Glycoprotein IIb/IIa Inhibitors vs. Bivalirudin and Paclitaxel-Eluting vs. Bare Metal Stents in STEMI by Dr. Gregg W. Stone (TCT 2009)

      -One-Year Outcomes of Primary Angioplasty in Acute Anterior Myocardial Infarction with Bivalirudin Compared to Unfractionated Heparin plus GP IIb/IIIa Inhibitors by Dr. Jochen Wöhrle (TCT 2009)

HYVET: The Hypertension in the Very Elderly Trial

      -Late-Breaking Clinical Trial Results Presented at ACC 2008 by Dr. Nigel S. Beckett

Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs